Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Bioconjugation

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!

Biomanufacturing

New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!

Danielle Alvarez

Pharma's Almanac

PAO-11-022-CL-11December 05, 2022

Vaccines Present a Novel Strategy for Opioid Overdose Prevention

Opioid Conjugate Vaccines

Vaccines Present a Novel Strategy for Opioid Overdose Prevention

Muctarr Sesay, Ph.D.

GBI

PAO-10-022-CL-07October 31, 2022

Theranostic Manufacturing Solutions

Theranostics

Theranostic Manufacturing Solutions

Muctarr Sesay, Ph.D.

GBI

PAO-08-022-CL-07August 29, 2022

Novel Off-The-Shelf Targeted Cell Therapies

In Conversation

Novel Off-The-Shelf Targeted Cell Therapies

Gary Lord; Dago Caceres; David Alvaro, Ph.D.; Sonny Hsiao, Ph.D.

Dow Chemicals

PAP-Q2-20-CL-021July 01, 2020